National Plastic Surgery Authority
Plastic surgery occupies a contested boundary in American medicine — simultaneously a board-certified surgical specialty, a consumer-facing industry, and a regulatory target for federal and state oversight bodies. This page maps the full scope of the field: its definition, classification boundaries, regulatory framework, and common misconceptions. Topics covered on this site range from safety thresholds and risk categories to frequently asked questions about procedures and credentialing.
Where the public gets confused
The most persistent public misconception about plastic surgery is that it is synonymous with cosmetic surgery. The two overlap but are not equivalent. The American Board of Medical Specialties (ABMS) recognizes plastic surgery as a distinct board-certified specialty. Cosmetic surgery, by contrast, has no standalone ABMS-recognized board — it is a practice descriptor applied across multiple specialties including dermatology, otolaryngology, and general surgery.
This distinction has real consequences. A physician advertising cosmetic procedures may be board-certified in plastic surgery, or may hold certification only in an unrelated field. The American Board of Plastic Surgery (ABPS), one of 24 member boards of the ABMS, sets the credentialing standard for the specialty. Completing a residency in general surgery followed by a fellowship in plastic surgery is the traditional pathway to ABPS certification — a process that typically spans 6 or more years of post-medical-school training.
A second source of confusion involves the word "elective." Reconstructive procedures — including post-mastectomy breast reconstruction, cleft palate repair in newborns, and burn scar revision — are medically indicated procedures that fall squarely within plastic surgery. Labeling all plastic surgery as elective mischaracterizes the clinical scope of the specialty and distorts insurance coverage conversations.
Boundaries and exclusions
Plastic surgery as a specialty has defined jurisdictional limits. The ABPS defines the field as encompassing procedures of the skin, soft tissue, musculoskeletal system, and craniofacial structures, as well as hand surgery and peripheral nerve surgery. Cardiac surgery, thoracic surgery, and neurosurgery are explicitly outside the scope even where incisions overlap anatomically.
Procedures performed by non-surgeons — such as injectable neurotoxins (e.g., botulinum toxin type A), dermal fillers administered by licensed nurse practitioners or physician assistants under physician supervision, and laser treatments performed by licensed aestheticians — sit at the boundary of plastic surgery but do not constitute surgery. Regulatory treatment of these procedures varies by state, with scope-of-practice statutes determining which licensed professionals may perform which interventions.
Oral and maxillofacial surgery (OMS), which holds dual dental and medical training pathways, overlaps with craniofacial plastic surgery. The boundary between the two specialties is actively contested in craniofacial reconstruction and jaw surgery, and institutions resolve these overlaps differently in their credentialing committees.
The regulatory footprint
Plastic surgery in the United States is regulated at multiple levels simultaneously.
Federal level: The U.S. Food and Drug Administration (FDA) regulates medical devices used in plastic surgery — including breast implants, tissue expanders, and dermal fillers classified as medical devices. Breast implants, for instance, carry FDA-mandated labeling requirements and a black box warning established in 2021 covering risks including Breast Implant-Associated Anaplastic Large Cell Lymphoma (BIA-ALCL) and Breast Implant Illness (BII). The FDA also regulates injectable botulinum toxin products (marketed under brand names including Botox, Dysport, and Xeomin) as biologics under the Public Health Service Act.
State level: Licensure, facility accreditation, and scope-of-practice rules are state-administered. Office-based surgical facilities operating outside hospital settings are subject to state health department inspection requirements that differ across the 50 states. The regulatory context for plastic surgery covered in detail on this site maps those state-level distinctions.
Accreditation bodies: The American Association for Accreditation of Ambulatory Surgery Facilities (AAAASF), the Accreditation Association for Ambulatory Health Care (AAAHC), and The Joint Commission each offer facility accreditation pathways. Some states require accreditation as a condition of operating an outpatient surgical facility; others accept it as a voluntary credential.
Insurance and coding: The Centers for Medicare & Medicaid Services (CMS) administers the ICD-10-CM and CPT coding systems that determine reimbursement eligibility, distinguishing reconstructive from cosmetic indications at the billing level. The Women's Health and Cancer Rights Act of 1998 (WHCRA) requires group health plans that cover mastectomies to also cover breast reconstruction — one of the few federal mandates directing plastic surgery coverage.
What qualifies and what does not
Category Examples Board Specialty Overlap Typically Insured?
Reconstructive plastic surgery Post-mastectomy reconstruction, cleft repair, burn revision ABPS primary Yes (condition-dependent)
Hand surgery Tendon repair, carpal tunnel release, replantation ABPS, orthopedics Yes
Craniofacial surgery Craniosynostosis correction, facial trauma ABPS, OMS, neurosurgery Yes (pediatric/trauma)
Cosmetic surgery (surgical) Rhinoplasty, facelift, abdominoplasty ABPS, otolaryngology, others Rarely
Minimally invasive cosmetic Botox, fillers, chemical peels Dermatology, ABPS, others No
Aesthetic non-surgical (non-physician) Laser hair removal, microneedling N/A (licensed aesthetician) No
The critical classification variable is medical necessity. The ABMS does not classify procedures; payers and coding authorities determine medical necessity through ICD-10 diagnosis linkage and pre-authorization review.
Primary applications and contexts
Plastic surgery operates across four primary clinical contexts:
Trauma and emergency reconstruction: Facial fracture repair, degloving injuries, and blast wound reconstruction are performed in Level I and Level II trauma centers by plastic surgeons integrated into trauma teams. This is among the highest-acuity work in the specialty.
Oncologic reconstruction: Following surgical tumor removal — most visibly in breast cancer surgery — plastic surgeons perform immediate or delayed reconstruction. Post-Mohs surgery reconstruction for skin cancers performed on the face is a high-volume application involving dermatology and plastic surgery coordination.
Congenital and pediatric correction: Cleft lip and palate repair, typically performed between 3 and 18 months of age depending on the structure involved, represents one of the highest-volume reconstructive pediatric procedures globally. Craniofacial teams at children's hospitals coordinate plastic surgery, neurosurgery, orthodontics, and speech pathology.
Elective aesthetic surgery: Cosmetic procedures motivated by appearance preferences rather than medical indication account for a significant share of plastic surgery volume. The American Society of Plastic Surgeons (ASPS) reported approximately 13.2 million surgical and minimally invasive cosmetic procedures performed by ASPS members in a single annual reporting period, with rhinoplasty, blepharoplasty, and liposuction consistently among the top five surgical procedures by volume.
How this connects to the broader framework
Plastic surgery does not exist as an isolated clinical silo. The specialty intersects with oncology, burn medicine, orthopedics, pediatric medicine, and dermatology in ways that require coordinated institutional frameworks. This site belongs to the Authority Network America family (authoritynetworkamerica.com), which provides reference-grade coverage across medical and professional specialties.
Understanding plastic surgery requires understanding the layered oversight structure that governs it — credentialing bodies, device regulators, facility accreditors, and payers each apply distinct standards that can conflict with one another. A procedure approved as a covered reconstructive benefit under one payer's policy may be classified as cosmetic under another's, using the same ICD-10 diagnosis code. These tensions are structural, not incidental.
The field also sits at the intersection of medicine and commerce in a way few other specialties do. Direct-to-consumer advertising of cosmetic procedures is legal and widespread, while the same procedure performed in a hospital context is subject to institutional review and credentialing oversight that outpatient cosmetic practices may not replicate.
Scope and definition
The ABPS defines plastic surgery formally as a specialty concerned with "the correction or restoration of form and function." That dual mandate — form and function — distinguishes plastic surgery from purely cosmetic practice and from purely reconstructive surgical specialties. The word "plastic" in the specialty name derives not from synthetic materials but from the Greek plastikos, meaning to mold or shape — though this etymology has no bearing on current scope definitions.
Procedural classification checklist (non-advisory):
-
[ ] Identify whether a procedure is surgical or non-surgical
-
[ ] Confirm the operating or performing provider's board certification and specialty
-
[ ] Identify whether the indication is reconstructive (medically indicated) or cosmetic (elective)
-
[ ] Confirm facility accreditation status (AAAASF, AAAHC, or Joint Commission)
-
[ ] Verify applicable state scope-of-practice rules for non-physician providers
-
[ ] Review payer-specific medical necessity criteria for the relevant ICD-10 diagnosis code
-
[ ] Confirm FDA device approval or clearance status for any implanted or injected device
Why this matters operationally
The stakes of misclassifying plastic surgery — as purely cosmetic, as unregulated, or as interchangeable with any surgical specialty — are concrete and institutional. Patients denied reconstructive coverage under a health plan may have federal statutory remedies under the WHCRA or state parity laws. Facilities operating without required accreditation expose operators to state health department enforcement actions. Providers performing procedures outside their training and credentialing scope face medical board disciplinary proceedings and civil liability exposure.
The FDA's 2021 breast implant labeling changes — adding a boxed warning, a patient decision checklist requirement, and a new contraindication list for patients with autoimmune conditions — restructured informed consent obligations for every plastic surgeon and facility implanting breast devices. Non-compliance is a regulatory violation, not merely a clinical judgment call.
For patients, the practical implication is that the credentialing verification process matters before any procedure, surgical or otherwise. The ABPS maintains a publicly searchable certification database. The how to get help for plastic surgery resource on this site addresses that verification process in structured form.
The specialty's dual identity — as a reconstructive medical discipline and as a consumer-facing cosmetic industry — means that the same terminology, the same procedure names, and the same provider titles can carry radically different regulatory meanings depending on context. Navigating that complexity requires reference-grade specificity, not generalizations.
References
-
American Association for Accreditation of Ambulatory Surgery Facilities (AAAASF)
-
Accreditation Association for Ambulatory Health Care (AAAHC)
The law belongs to the people. Georgia v. Public.Resource.Org, 590 U.S. (2020)